PubMed Health⌕ Search

Biomedical subjects

F Blecha

Publications and source records attributed to F Blecha.

At least 55 records · Page 3Linked to original sources

Leukocyte functions of young dairy calves fed milk replacers supplemented with vitamins A and E.

Holstein calves (n = 44) were fed milk replacers from d 3 to 45 with low or high concentrations of vitamin A (7000 or 87,000 IU/kg) and vitamin E (11.2 or 57 IU/kg) to examine the influence of vitamin concentrations on vitamin bioavailability and leukocyte functions. Concentrations of alpha-tocopherol in plasma reflected increased vitamin E but were unaffected by increased vitamin A. Plasma retinol concentrations were greatest with high supplementation of vitamins A and E at wk 3; however, at wk 6, plasma of calves fed high vitamin A and low vitamin E contained the most retinol. Increased supplementation of vitamin A improved fecal consistency compared with that for calves fed the low vitamin A diet at wk 3 and 4. At wk 3, calves that received increased supplementation of vitamins E and A had enhanced neutrophil bactericidal activity compared with that of calves with increased individual vitamins. Lymphocyte DNA synthesis and chemotactic index were unaffected by dietary treatments. Results indicate that increased vitamin A in milk replacer did not affect plasma vitamin E concentrations, benefited fecal scores regardless of vitamin E concentrations, but was only beneficial to bactericidal activity of neutrophils in conjunction with increased vitamin E.

Animal Feed↗

Isolation and characterization of monoclonal antibodies to recombinant bovine interleukin-1 beta.

We describe the preparation of monoclonal antibodies (Mabs) directed against recombinant bovine interleukin-1 beta (rBoIL-1 beta). These anti-IL-1 beta Mabs were designated SA10, SA12, SA13, SA15, and SA22, and were characterized on the basis of their epitope specificity and cross-reactivity with homologous and heterologous cytokines in enzyme-linked immunosorbent assays and immunoblot analyses. Additionally, the ability of these Mabs to neutralize IL-1 beta was tested in thymocyte costimulation assays. The ELISA titers of all Mabs ranged from 9.4 x 10(6) to 1 x 10(7). Data indicate that Mabs SA10, SA12, SA15, and SA22 neutralized both bovine macrophage-derived IL-1 (1:4) and rBoIL-1 beta (1 ng ml-1). All the Mabs against rBoIL-1 beta (SA10, SA12, SA13, SA15, SA22) were specific and did not cross-react with other cytokines tested, except recombinant human IL-1 beta (rHuIL-1 beta). This finding suggests that these Mabs recognize epitopes common to human and bovine IL-1 molecules. Competition experiments suggested that Mab SA22 recognized a different epitope and Mabs SA10, SA12, SA13, and SA15 recognized the same epitope on the rBoIL-1 beta molecule. These observations suggest that these Mabs could be useful reagents for developing immunoassays to measure bovine IL-1 beta from biological fluids and to study the immunoregulatory role of IL-1 in the bovine immune system.

Animals↗

Immunopotentiation of bovine respiratory disease virus vaccines by interleukin-1 beta and interleukin-2.

Three experiments, using 85 crossbred beef calves, were conducted to evaluate the adjuvanticity of single, multiple, and combined doses of recombinant bovine IL-1 beta (rBoIL-1 beta) and recombinant bovine IL-2 (rBoIL-2), with a modified-live bovine herpesvirus-1/parainfluenza-3 (BHV-1/PI-3) virus vaccine and a killed bovine viral diarrhea (BVD) virus vaccine. Cytokines were administered intramuscularly at vaccination but at different injection sites. All cytokine treatments increased non-major histocompatibility complex (MHC)-restricted cytolytic capability of peripheral blood mononuclear cells (PBMC) against virus-infected target cells and serum neutralizing (SN) antibody titers to BHV-1 and BVD virus. Multiple, consecutive injections of rBoIL-2 generally showed the greatest adjuvant effect, and no additive effect was observed when rBoIL-1 beta and rBoIL-2 were administered together. In a challenge experiment, calves were vaccinated with a modified-live BHV-1/PI-3 vaccine and infected with BHV-1 on Day 21. Cytokine-treated calves had higher SN antibody titers to BHV-1 than did the control calves at the time of challenge. Calves that were administered rBoIL-2 on 5 consecutive days shed less BHV-1 and had the highest SN antibody titer to BHV-1 (Day 28). These data suggest that rBoIL-1 beta and rBoIL-2 may be useful immunoadjuvants for bovine respiratory disease virus vaccines.

Adjuvants, Immunologic↗

Comparison of bovine immune responses to affinity-purified bovine herpesvirus-1 antiidiotypes and glycoproteins.

Bovine immune responses to rabbit antiidiotypic antibodies (anti-Id) against neutralizing monoclonal antibodies to bovine herpesvirus-1 (BHV-1) envelope glycoproteins and to BHV-1 glycoproteins were compared. Glycoprotein-immunized animals produced high titers of anti-BHV-1 antibodies and were protected against BHV-1 challenge. Recombinant bovine interleukin-2 (rIL-2)-treated, anti-Id-immunized animals showed a slight reduction in clinical disease, and one calf produced BHV-1-neutralizing antibodies. Treatment with rIL-2 augmented non-BHV-1-specific immune responses. However, even with rIL-2 as an adjuvant, the mixture of polyclonal anti-Id did not elicit a consistent, protective BHV-1-specific immune response in calves.

Animals↗

The effect of pre- and postweaning exposure to soybean meal on growth performance and on the immune response in the early-weaned pig.

The effect of pre- and postweaning exposure to soybean meal on postweaning growth performance and immune response by the early-weaned pig was analyzed. In Exp. 1, treatments were assigned in a 2 x 2 x 2 factorial arrangement. Pigs were derived from gilts fed either a soybean meal- or a corn gluten meal-based diet during gestation and lactation. Six to eight pigs per litter were either stomach-infused with or without (placebo) soybean meal during d 5 to 9 after farrowing. At weaning, 240 pigs (initially 5.1 kg, 21 +/- 1 d) were randomly allotted to either a corn-soybean meal or a corn-dried skim milk-dried whey diet based on gilt and infusion treatments. Average daily gain, ADFI, and gain:feed ratio were decreased (P < .05) on d 0 to 14 postweaning for pigs fed a soybean meal diet compared with pigs fed a milk diet. Skin-fold thickness after intradermal injection of soy protein and casein extracts on d 6 and measured on d 7 postweaning was not affected (P > .10) by dietary treatment, but serum immunoglobulin G titers to soybean glycinin and beta-conglycinin were increased (P < .01). From d 14 to 35 postweaning, all pigs were fed a common (1.25% lysine) corn-soybean meal diet containing 10% dried whey. Average daily gain, ADFI, and gain:feed ratio were decreased (P < .05) from d 14 to 35 for pigs fed a milk diet on d 0 to 14 postweaning. Serum immunoglobulin G titers were higher (P < .01) on d 21 postweaning for pigs fed soybean meal for the entire nursery period. Cumulative ADG (d 0 to 35) and gain:feed ratio were decreased (P < .05) for pigs fed a milk diet from d 0 to 14 compared with pigs fed a soybean meal diet. In Exp. 2, 104 pigs (initially 5.3 kg, 21 +/- 1 d of age) were used to determine the effect of 0, 7.5, 15.0, and 22.5% soybean meal in a high-nutrient-dense starter pig diet. Differences were not detected (P > .10) in ADG, ADFI, and gain:feed ratio during d 0 to 14, but ADFI decreased (linear, P < .05) and gain:feed ratio increased (linear, P < .05) during d 14 to 35 and for the entire 35-d trial as the level of soybean meal increased.(ABSTRACT TRUNCATED AT 400 WORDS)

Adaptation, Physiological↗

Lymphocyte proliferative responses in neonatal pigs with high or low plasma cortisol concentration after stress induced by restraint.

High plasma cortisol concentration is associated with perception of stress and reduced immune function in pigs. Neonatal pigs (12, 19, or 26 days old) were tested to determine maximal cortisol response to a mild restraint stressor. Pigs were fitted with indwelling jugular cannulas 4 days prior to restraint. One day before restraint, 10 ml of blood was removed for lymphocyte isolation and subsequent in vitro lymphocyte proliferation and interleukin 2 (IL-2) assays. On the day of restraint, blood samples were drawn 10 minutes before and 3, 10, and 20 minutes after holding each pig in a supine position for 1 minute. Plasma cortisol concentration was determined by use of radioimmunoassay. Pigs with maximal cortisol response greater than the mean value for that age group were classified in the high-responder (HIRES) group. Conversely, those with values lower than the mean maximal response were assigned to the low-responder (LORES) group. The HIRES pigs had larger relative adrenal gland weights and higher baseline and maximal cortisol responses, compared with LORES pigs (P = 0.0170, P = 0.0002, P = 0.0001, respectively). Mitogen-induced lymphocyte proliferative responses (to phytohemagglutinin, concanavalin A, and pokeweed mitogen) were 60% lower (P = 0.0037, P = 0.0432, P = 0.0103, respectively) in HIRES vs LORES pigs. In vitro IL-2 production did not differ between HIRES and LORES pigs.

Aging↗

Anti-idiotypic antibodies to bovine herpesvirus-1 inhibit virus infection in cell cultures.

A panel of murine monoclonal antibodies (MAbs) to bovine herpesvirus-1 (BHV-1) was prepared. Three of them were neutralizing MAbs and reacted against 130/75/50 kDa, 77 kDa, or 97 kDa glycoproteins (gp). A fourth non-neutralizing MAb recognized the 97 kDa gp. Competition radioimmunoassay demonstrated that each of the four MAbs reacted against a different virus epitope. Anti-idiotypic antibodies (anti-id) to the four MAbs were produced in rabbits and purified by sequential immunoaffinity chromatography. Each anti-id inhibited the binding of its respective MAb to BHV-1 in competitive ELISA and blocked BHV-1 neutralizing activity of the MAb. This inhibition suggested that the anti-ids were specific for the antigen binding site of the MAbs. Treatment of MDBK cells with anti-ids inhibited BHV-1 infection, which suggested that the anti-ids block a cellular component essential for virus infection. Absence of significant cross-reactivity among the anti-ids for heterologous MAbs indicated that they recognized unique determinants on the antigen binding site of the homologous MAb.

Animals↗

Interleukin 2 treatment of Staphylococcus aureus mastitis.

A study was conducted in dairy cows to evaluate the efficacy of recombinant bovine interleukin 2 (rBoIL-2) as an adjunct to antibiotic therapy in Staphylococcus aureus mastitis. In normal, non-mastitic cows, intramammary infusion of rBoIL-2 caused a tenfold increase in somatic cell counts (SCC) in milk. Co-administration of 2 mg of rBoIL-2 and sodium cephapirin in cows with established S. aureus mastitis decreased SCC and shedding of S. aureus compared with values from cows that were given only sodium cephapirin or 10 mg rBoIL-2 with sodium cephapirin. Cows in the 2 mg rBoIL-2 group cleared the infection earlier and at 2 weeks after treatment had not relapsed with staphylococcal mastitis. These data suggest that rBoIL-2 may be useful as an immunotherapeutic agent in controlling mastitis.

Animals↗

Repeated restraint and isolation stress alters adrenal and lymphocyte functions and some leukocyte differentiation antigens in lambs.

Lambs were used to evaluate the effect of repeated restraint and isolation stress (RIS) on secretion of cortisol, lymphocyte proliferative responses to mitogens, production of interleukin-2, and expression of leukocyte differentiation antigens. Differentiation antigens evaluated included cluster of differentiation antigens 2, 4, and 8 (CD2, CD4, and CD8, respectively); B cells; and major histocompatibility complex (MHC) class II, DQ, and DR. Lambs were assigned to either control (CON; n = 12) or to RIS treatment (n = 12) then were stanchioned in environmentally controlled rooms at 18 degrees C and constant light for 11 d before jugular vein catheters were inserted on d 0 of the experiment. On d 12, 13, and 14, lambs in the RIS treatment were removed to another location, restrained, and isolated from visual and tactile contact with other lambs for 6 h on each day. Following the 6-h stress treatment, lambs were returned to their home stanchions. The CON lambs remained in their stanchions. Samples of serum were obtained from all lambs, beginning before RIS (0 h) and at .5-h intervals until the completion of stress (6 h) on d 12 and 14. In addition, samples of whole blood were obtained at 0 and 6 h on d 12, 13, and 14 for evaluation of immune function characteristics. Fitted polynomial curves describing the cortisol response in RIS and CON lambs differed (P less than .005) on both d 12 and 14, reflecting the unmistakable increase in cortisol in response to the stressor.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

Neutrophil and lymphocyte response to supplementation with vitamins C and E in young calves.

Calves, beginning at 3 d of age, were bottle-fed milk replacer unsupplemented, or supplemented with 10 g of vitamin C, or supplemented with 10 g of vitamin C plus 57 IU of vitamin E/kg of dry milk replacer (10 calves per treatment). Neutrophils from wk 2 and 4 blood samples were assayed for Staphylococcus aureus phagocytosis and neutrophil-mediated, antibody-dependent cellular cytotoxicity, and lymphocytes from those samples were assayed for concanavalin A-induced, phytohemagglutinin-induced, or pokeweed mitogen-induced proliferation. Ocular and nasal discharges of calves supplemented with vitamins C or C and E were less than those of controls for wk 1 to 8. Calves receiving supplementation with vitamin C and E tended to have higher mitogen-induced lymphocyte proliferative responses at wk 2. Neutrophil-mediated phagocytosis and antibody-dependent cellular cytotoxicity were lower at wk 2 and 4 for calves supplemented with vitamin C than for controls. Neutrophil function of calves supplemented with vitamins C and E together was near, or slightly higher than, that of unsupplemented calves for wk 2 and 4, suggesting that the addition of vitamin E negated the adverse effects that vitamin C alone had on neutrophil functions.

Animals↗

Pulmonary intravascular macrophages: a review of immune properties and functions.

Pulmonary intravascular macrophages (PIMs) are mononuclear cells found apposed to the lung capillary endothelium in a number of mammalian species. Although first described in the 1970s, it was not until the 1980s that they were more completely described. In several species of veterinary interest (bovine, porcine, ovine, and feline), PIMs are very important in blood clearance, which is not the case in mice and rats. Only recently have the immunological activities of PIMs been verified. In this review, we present an overview of PIM research with particular emphasis on the immune functions of this highly reactive macrophage population.

Animals↗

Porcine alveolar and pulmonary intravascular macrophages: comparison of immune functions.

Although a substantial amount of information is available on pulmonary alveolar macrophages (PAMs), little is known about pulmonary intravascular macrophages (PIMs), a separate population of lung macrophages found apposed to the endothelium of pulmonary capillaries. We compared these two populations of lung immunocytes to determine their relative immunological activity. Our results suggest that PAMs are more phagocytic than PIMs; however, PIMs may be more efficient at lysing ingested bacteria than PAMs. Although similar in antibody-dependent cellular cytotoxicity, PIMs are more spontaneously cytolytic than PAMs. Depending upon the effector:target cell ratio studied, the tumoricidal activity of PIMs was less than or equal to that of PAMs. Both cell populations produced the cytokines interleukin-1 and tumor necrosis factor-alpha at similar concentrations. These data suggest that PIMs are immunologically active, although the degree of activity may differ between PIMs and PAMs.

Animals↗

Anti-idiotypic antibodies mimic bovine viral diarrhea virus antigen.

Polyclonal rabbit anti-idiotypic antibodies (anti-ids) against two neutralizing murine monoclonal antibodies (mAbs) specific to a bovine viral diarrhea virus (BVDV) glycoprotein, 53 kDa, were produced, purified, and characterized. Each anti-id inhibited the binding of its respective mAb to BVDV antigen in a competitive ELISA and blocked the immunoprecipitation of the 53 kDa protein by the mAb. The anti-ids also inhibited the virus-neutralizing activity of their homologous mAbs. These results suggest that the anti-ids bear an internal image of a BVDV antigen and mimic neutralizing epitopes on the 53 kDa protein. Treatment of MDBK cells with the anti-ids inhibited BVDV infection, indicating that they block a cellular component, such as a virus receptor, required for virus adsorption or entry. Inhibition of the homologous mAb and lack of inhibition of the heterologous mAb indicate that the anti-ids are specific for the unique antigen-binding sites on the mAbs.

Animals↗

Induction of immune response to bovine herpesvirus-1 with anti-idiotypic antibodies.

Previously, we prepared rabbit anti-idiotypic (anti-Id) antibodies against murine monoclonal antibodies (MAbs) specific for the major bovine herpesvirus-1 (BHV-1) envelope glycoproteins. Glycoprotein III (gIII) contains neutralization epitopes and may be the virus attachment protein. Anti-Id antibodies to a neutralizing MAb that reacts with gIII were purified by sequential immunoaffinity chromatography. Immune responses to the purified anti-Id reagent and BHV-1 were compared in mice. Both groups of mice produced BHV-1-specific neutralizing antibodies. However, lymphocyte proliferative responses and interferon and interleukin-2 production were specific for the respective immunizing antigens. These results suggest that the anti-Id reagent may bear an internal image of a B-cell-stimulating epitope of glycoprotein gIII; however, this epitope does not stimulate a virus-specific cellular immune response in mice.

Animals↗

Interrelationship between hypersensitivity to soybean proteins and growth performance in early-weaned pigs.

The objective of this growth trial was to determine the interrelationship between immunological criteria, gut morphology, and performance of starter pigs fed soybean proteins processed by different methods. One hundred twenty-five pigs were orally infused with 6 g/d of either dried skim milk, soybean meal (48% CP), soy protein concentrate, extruded soy protein concentrate, or experimental soy protein concentrate from 7 to 11 d of age and then fed a diet containing the same protein sources from weaning (d 21) to 35 d of age. All pigs were fed a corn-soybean meal diet containing 10% dried whey, 1.25% lysine, and 3% soybean oil for the remaining 21 d of the experiment. Xylose absorption and anti-soy immunoglobulin G (IgG) titers were measured on d 6 postweaning, and skin-fold thickness after intradermal injection of protein extracts was measured on d 7 postweaning. A total of 25 pigs (five pigs/treatment) was euthanatized on d 7 postweaning. Villus height and crypt depth from duodenum samples were measured. These measurements were obtained to elucidate a relationship between the hypersensitivity responses to soybean products and growth performance of baby pigs. Pigs fed diets containing soybean meal had a lower (P less than .05) rate of gain (d 0 to 14) and villus height, higher (P less than .01) serum anti-soy IgG titers, and increased skin-fold thickness (d 6 and 7 postweaning) after intradermal injection compared with those fed dried skim milk. Pigs fed other soy proteins also had lower ADG from d 0 to 14 postweaning; however, pigs fed moist extruded soy protein concentrate tended (P less than .09) to have higher ADG and improved feed utilization when compared with pigs fed soybean meal (d 0 to 14).(ABSTRACT TRUNCATED AT 250 WORDS)

Animal Feed↗

Removal of nocturnal secretion of melatonin fails to reduce antibody synthesis and interleukin-2 production of lambs.

Crossbred ewe and wether lambs were used to evaluate the effects of a normal, nocturnal elevation in the concentration of melatonin in the serum on immunological functions. The nocturnal elevation in melatonin was eliminated by exposing half the lambs to constant light (LL), whereas the remainder received a 12-h light, 12-h dark cycle (LD). Immune function was challenged by treating half the lambs in LL and half of the lambs in LD with dexamethasone (DEX; .04 mg/kg); the remainder of the lambs received only a saline vehicle (SAL). The resulting treatment combinations were designated LD+SAL (n = 5), LD+DEX (n = 5), LL+SAL (n = 5), and LL+DEX (n = 5). Lambs were stanchioned individually in environmental rooms; photoperiod treatments commenced on that day (d -14). Also on d -14, lambs were given 1 mg ovalbumin/lamb in adjuvant. Lambs were given a booster injection of .5 mg ovalbumin/lamb on d 0. Treatments with DEX and SAL also began on d 0 and were repeated every 48 h through d 14. Catheters were placed in the jugular vein of all lambs on d 12; samples of plasma and serum were collected hourly from 0800 on d 14 to 0800 on d 15; plasma was assayed for adrenocorticotropic hormone (ACTH) and serum was assayed for cortisol and melatonin. In addition, samples of serum obtained at 0800 on d 15 were used to evaluate antibody titers to ovalbumin. Samples of whole blood also were obtained at 0800 on d 15, and total and differential leukocyte numbers and production of interleukin-2 (IL-2) by lymphocytes were determined.(ABSTRACT TRUNCATED AT 250 WORDS)

Adrenocorticotropic Hormone↗

Repeated restraint and isolation stress in lambs increases pituitary-adrenal secretions and reduces cell-mediated immunity.

Rambouillet crossbred ewe lambs were used to evaluate the effect of repeated restraint and isolation stress (RIS) on endocrinological and immunological functions. Lambs were blocked by weight and assigned to either RIS (n = 6) or to control (CON; n = 6) treatments. All lambs were tethered in environmentally controlled rooms at 22 degrees C with constant light and, at this time (d 0), were given 1 mg of ovalbumin in adjuvant. On d 12, catheters were placed nonsurgically into the jugular vein of all lambs, and they were reimmunized with .5 mg of ovalbumin in incomplete adjuvant. Each lamb in the RIS treatment group was removed from its home stanchion, isolated from visual and tactile (but not auditory and olfactory) contact with other lambs, and restrained for 6 h on d 14, 15, and 16. Lambs in CON treatment remained undisturbed in their home stanchions. Lymphocyte blastogenic function and production of interleukin-2 (IL-2) were assessed in samples of blood collected before and at the conclusion (0 and 6 h) of each of the three stress bouts. In addition, ACTH and cortisol secretion in response to RIS was evaluated in samples of plasma and serum collected at .5-h intervals on the first and last days of stress (d 14 and 16). Finally, antibody production in response to immunization against ovalbumin was assessed in samples of serum obtained 14 d after reimmunization on d 12 of the study. Polynomial curves fit to the ACTH and cortisol data differed (P less than .005) on both d 14 and 16 between RIS and CON treatments.(ABSTRACT TRUNCATED AT 250 WORDS)

Adrenocorticotropic Hormone↗

Cell-mediated immune function in lambs chronically treated with dexamethasone.

Crossbred ewe and wether lambs were individually stanchioned in environmentally controlled rooms at 20 degrees C. On d 0, lambs were treated with .04 mg of dexamethasone (DEX; n = 10)/kg of BW or given an equal volume of saline vehicle (SAL; n = 10). Treatment was repeated every 48 h for 14 d. Samples of blood were obtained by puncture of the jugular vein on d 0 (before treatment), 2, 4, 7, 10, and 14. Total and differential leukocyte numbers, lymphocyte blastogenic responses to mitogens, and in vitro production of interleukin-2 (IL-2) were determined. No treatment x day interaction was noted for any of the experimental end points (P greater than .10); therefore, within-day comparisons between DEX- and SAL-treated lambs were not made. However, over all 14 d, DEX-treated lambs had increased (P less than .05) numbers of lymphocytes (6.5 +/- .4 vs 5.1 +/- .4 x 10(3) cells/microliters for SAL) and monocytes (.8 +/- .1 vs .6 +/- .1 x 10(3) cells/microliters for SAL), and these increases contributed to an increase (P less than .01) in total leukocytes (11.2 +/- .5 vs 9.1 +/- .5 x 10(3) cells/microliters for SAL). Lymphocyte blastogenic responses to mitogens were not affected by DEX treatment. Production of IL-2 was reduced (P less than .05) for DEX- (.90 +/- .12 units/ml) compared with SAL-treated lambs (1.27 +/- .13 units/ml). The data suggest that continued treatment of lambs with DEX may result in a modest reduction in production of IL-2, but mitogen-stimulated blastogenic responses of lymphocytes are not reduced by DEX treatment.

Animals↗